Brokerages Set Celsius Holdings, Inc. (NASDAQ:CELH) Price Target at $45.00

Celsius Holdings, Inc. (NASDAQ:CELH - Get Free Report) has received a consensus rating of "Moderate Buy" from the seventeen ratings firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have issued a buy rating on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $45.29.

A number of brokerages recently weighed in on CELH. JPMorgan Chase & Co. began coverage on shares of Celsius in a research note on Thursday, December 12th. They set an "overweight" rating and a $37.00 price target for the company. LADENBURG THALM/SH SH reduced their target price on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating for the company in a research note on Thursday, March 27th. B. Riley reiterated a "buy" rating and set a $49.00 price target (up from $44.00) on shares of Celsius in a research note on Friday, February 21st. UBS Group reduced their price objective on shares of Celsius from $45.00 to $39.00 and set a "buy" rating for the company in a research report on Thursday, January 16th. Finally, Truist Financial raised Celsius from a "hold" rating to a "buy" rating and increased their target price for the stock from $35.00 to $45.00 in a research note on Monday, March 31st.

Celsius Trading Up 5.4 %

CELH stock traded up $1.85 during trading on Friday, hitting $35.74. 2,758,941 shares of the company's stock were exchanged, compared to its average volume of 7,624,948. The business has a 50-day moving average price of $28.40 and a two-hundred day moving average price of $28.90. The stock has a market capitalization of $8.40 billion, a price-to-earnings ratio of 81.11, a PEG ratio of 2.90 and a beta of 1.58. Celsius has a 52-week low of $21.10 and a 52-week high of $98.85.

Remove Ads

Celsius (NASDAQ:CELH - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.11 by $0.03. The firm had revenue of $332.20 million for the quarter, compared to analyst estimates of $326.07 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. On average, equities research analysts anticipate that Celsius will post 0.89 earnings per share for the current fiscal year.

Insider Transactions at Celsius

In other news, Director Joyce Russell sold 4,000 shares of Celsius stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total transaction of $113,880.00. Following the completion of the sale, the director now directly owns 19,106 shares in the company, valued at $543,947.82. The trade was a 17.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares of the company's stock, valued at approximately $1,167,303.69. This represents a 18.36 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company's stock.

Institutional Investors Weigh In On Celsius

A number of institutional investors have recently added to or reduced their stakes in the company. HM Payson & Co. grew its holdings in shares of Celsius by 122.2% during the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company's stock worth $26,000 after purchasing an additional 550 shares during the period. MassMutual Private Wealth & Trust FSB lifted its position in Celsius by 255.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock valued at $37,000 after buying an additional 750 shares in the last quarter. S.A. Mason LLC grew its stake in Celsius by 100.0% during the fourth quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock worth $37,000 after buying an additional 700 shares during the period. GAMMA Investing LLC raised its stake in shares of Celsius by 185.7% in the 4th quarter. GAMMA Investing LLC now owns 1,714 shares of the company's stock valued at $45,000 after acquiring an additional 1,114 shares during the period. Finally, Blue Trust Inc. raised its stake in shares of Celsius by 32.8% in the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company's stock valued at $47,000 after acquiring an additional 441 shares during the period. Hedge funds and other institutional investors own 60.95% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.